CONN P JEFFREY has a total of 31 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ALMIRALL PRODESFARMA SA, CALASIA PHARMACEUTICALS INC and BIOPROJET SOC CIV.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 29 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Conn P Jeffrey | 31 |
#2 | Lindsley Craig W | 29 |
#3 | Niswender Colleen M | 15 |
#4 | Jones Carrie K | 14 |
#5 | Weaver Charles David | 13 |
#6 | Hopkins Corey R | 11 |
#7 | Rodriguez Alice L | 8 |
#8 | Stauffer Shaun R | 7 |
#9 | Gogliotti Rocco D | 7 |
#10 | Engers Darren W | 7 |
Publication | Filing date | Title |
---|---|---|
US2013245043A1 | Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptors | |
US2012172391A1 | Naphthyridinone analogs as mGluR5 positive allosteric modulators | |
US2011124663A1 | Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | |
WO2010114909A1 | Sulfonyl-piperidin-4-yl methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders | |
US2009042855A1 | Benzamide mGluR5 positive allosteric modulators and methods of making and using same | |
WO2005007096A2 | Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |